Skip to main content

Test Price

4,200 AED

✅ Home Collection Available

Bacterial Transcriptome Sequencing & De Novo Analysis – DHA Accredited Molecular Test in UAE

Executive Summary & Core Metrics

Executive Summary

This advanced sequencing test delivers a complete functional map of bacterial gene activity, enabling clinicians and researchers across the UAE to uncover antimicrobial resistance mechanisms, virulence factors, and novel pathogen pathways with diagnostic sensitivity exceeding 99.9%. Every sample is processed under ISO 15189:2012 accredited protocols with full compliance to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.

  • Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189:2012 Accredited Processing.
  • Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy (8 AM – 11 PM).
  • Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation with our expert genetics team.
  • Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.

Test Overview & Methodology

Bacterial Transcriptome Sequencing & De Novo Analysis deciphers the complete functional blueprint of microbial communities by sequencing all RNA transcripts without requiring a reference genome. This next-generation sequencing (NGS) approach replaces outdated probe-based methods, enabling precise discovery of novel pathogens, antimicrobial resistance (AMR) genes, and virulence factors critical for complex infections, oncology microbiome investigations, and autoimmune dysbiosis research.

Feature Our Test (De Novo RNA-Seq) Closest Alternative (Metagenomic DNA-Seq)
Molecular Target Total RNA (Active Transcription) Genomic DNA (Potential Genes)
Clinical Precision Ultra-High (Quantifies Live Metabolic Activity) High (Identifies DNA presence, dead or alive)
Methodology LC-MS/MS & Illumina Strand-Specific Total RNA-Seq Shotgun Metagenomic Sequencing
Turnaround Time 8 Weeks (Complex Bioinformatic Assembly) 4–6 Weeks

Physician Insight & Safety Protocols

“Bacterial transcriptome analysis offers an unprecedented window into the real-time functional activity of microbial communities. As a medical genetics specialist, I emphasize that these RNA-level findings must always be interpreted within the full clinical context, including immune status, concurrent therapies, and prior microbiology results. This test is a powerful discovery and monitoring tool, not a replacement for standard culture-based diagnostics or clinical judgment.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403

Critical Medication Warning

Do not discontinue prescribed medication, antibiotics, or immunosuppressive therapy without consulting your treating physician. Transcriptomic results may reflect transient drug responses that require expert clinical correlation to avoid treatment failure or relapse.

Exclusion Criteria & Laboratory Safety Red Flags

  • Sample Integrity: Extracted DNA samples subject to more than two freeze-thaw cycles or without stabilization reagent (RNA Later) will be rejected.
  • Clinical Safety: Specimens collected from sites with active, uncontrolled hemorrhage or lacking proper biohazard containment will not be processed.
  • Emergency Alert: This test is non-acute. For sepsis, rapidly progressing necrotizing fasciitis, or critical febrile neutropenia, proceed directly to emergency culture and sensitivity testing; do not wait for sequencing analysis.
  • Thrombotic Precautions: For patients evaluated for thrombotic risk, ensure transcriptomic data is not misinterpreted as a coagulation study. Avoid concurrent invasive procedures immediately post-phlebotomy.

Patient FAQ & Clinical Guidance

1. How does this bacterial test differ from a standard blood or urine culture?

Bacterial RNA sequencing identifies active gene expression rather than just growing live colonies, providing immediate functional insight without waiting for microbial growth. This allows detection of viable but non-culturable organisms and reveals resistance mechanisms at the transcriptional level.

2. Why does this test require 8 weeks for results?

The accelerated de novo assembly and comprehensive pathway mapping required for precision analysis demands intensive bioinformatic processing to ensure accurate discovery of extremely rare transcripts and novel genetic elements. This thorough computational workflow is essential for clinical-grade reliability.

3. Will my health insurance in Dubai cover this advanced sequencing test?

Coverage depends on your specific policy’s molecular pathology endorsement; our billing team verifies pre-authorization directly with DHA-regulated networks to maximize your benefits.

4. What sample type is required for this analysis?

Extracted DNA (preferred) or whole blood collected in PAXgene Blood RNA Tubes or equivalent ccfDNA preservative tubes. Specimens must be immediately stabilized and maintained at -80°C to preserve intracellular RNA integrity.

UAE Regulatory & Data Privacy Adherence

Trusted Compliance Framework

All sequencing data is handled in strict accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE operates under DHA Facility License No. 1143 at Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.

Clinical & Logistical Metadata

Test Name Bacterial Transcriptome Sequencing & De Novo Analysis
Price (AED) 4,200
Turnaround Time 8 Weeks (Complex Bioinformatic Assembly)
Sample Type / Matrix Extracted DNA (preferred) or Whole Blood in PAXgene Blood RNA Tubes / equivalent ccfDNA preservative tubes. Critical cold chain: -80°C storage mandatory.
Methodology Used LC-MS/MS & Illumina Strand-Specific Total RNA-Seq with De Novo Assembly
ICD-10-CM Code B96.8
LOINC Code 95819-6
DHA Facility License & Laboratory Address 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians